001     186295
005     20230317124310.0
024 7 _ |a pmid:17390727
|2 pmid
024 7 _ |a 0033-7587
|2 ISSN
024 7 _ |a 1938-5404
|2 ISSN
037 _ _ |a GSI-2016-00793
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Fournier, C.
|0 P:(DE-Ds200)OR0311
|b 0
|u gsi
245 _ _ |a Cell cycle-related bystander responses are not increased with LET after heavy-ion irradiation.
260 _ _ |a Great Falls, Va.
|c 2007
|b Radiation Research Society
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a article
|2 DRIVER
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1464132759_16055
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
520 _ _ |a Evidence has accumulated that irradiated cells affect their unirradiated neighbors, so that they in turn display cellular responses typically associated with direct radiation exposure. These responses are generally known as bystander effects. In this study, cell cycle-related bystander responses were investigated in three strains of human fibroblasts after exposure to densely ionizing radiation. Varying the linear energy transfer (LET) from 11 to 15,000 keV microm(-1) allowed a study of the impact of the complexity of DNA damage in the inducing cells on the responses of bystander cells. Using both broad-beam and microbeam irradiation, transient bystander responses were obtained for the induction of CDKN1A (p21). The latter was also observed when the transmission of bystander signals was limited to soluble factors. Targeted irradiation of single cells in confluent cell monolayers revealed no correlation between the amount of CDKN1A protein in the bystander cells and the radial distance to the targeted cells. In line with the induction of CDKN1A in bystander cells after irradiation with different LETs, a transient delay in the first G1 phase after irradiation of G0/G1 cells was observed. However, the CDKN1A induction revealed no significant effect on premature terminal differentiation considered to underlie fibrosis in irradiated tissue. Thus the unchanged differentiation pattern in bystander cells does not indicate pronounced, long-lasting effects.
536 _ _ |a 899 - ohne Topic (POF3-899)
|0 G:(DE-HGF)POF3-899
|c POF3-899
|f POF III
|x 0
536 _ _ |a 310 - Krebsforschung (POF1-300)
|0 G:(DE-HGF)POF1-310
|c POF1-300
|f POF I
|x 1
588 _ _ |a Dataset connected to PubMed,
650 _ 7 |a CDKN1A protein, human
|2 NLM Chemicals
650 _ 7 |a Cyclin-Dependent Kinase Inhibitor p21
|2 NLM Chemicals
650 _ 7 |a Ions
|2 NLM Chemicals
700 1 _ |a Becker, D.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Winter, M.
|0 P:(DE-Ds200)BUDP1-0340
|b 2
|u gsi
700 1 _ |a Barberet, P.
|0 P:(DE-Ds200)BUDP1-0013
|b 3
|u gsi
700 1 _ |a Heiss, M.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Fischer, B.
|0 P:(DE-Ds200)OR0301
|b 5
|u gsi
700 1 _ |a Topsch, J.
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Taucher-Scholz, G.
|0 P:(DE-Ds200)OR1282
|b 7
|u gsi
773 _ _ |g Vol. 167, no. 2
|0 PERI:(DE-600)2135113-2
|n 2
|p -
|t Radiation research
|v 167
|y 2007
|x 0033-7587
909 C O |o oai:repository.gsi.de:186295
|p VDB
910 1 _ |a GSI Helmholtzzentrum für Schwerionenforschung GmbH
|0 I:(DE-Ds200)20121206GSI
|k GSI
|b 0
|6 P:(DE-Ds200)OR0311
910 1 _ |a GSI Helmholtzzentrum für Schwerionenforschung GmbH
|0 I:(DE-Ds200)20121206GSI
|k GSI
|b 2
|6 P:(DE-Ds200)BUDP1-0340
910 1 _ |a GSI Helmholtzzentrum für Schwerionenforschung GmbH
|0 I:(DE-Ds200)20121206GSI
|k GSI
|b 3
|6 P:(DE-Ds200)BUDP1-0013
910 1 _ |a GSI Helmholtzzentrum für Schwerionenforschung GmbH
|0 I:(DE-Ds200)20121206GSI
|k GSI
|b 5
|6 P:(DE-Ds200)OR0301
910 1 _ |a GSI Helmholtzzentrum für Schwerionenforschung GmbH
|0 I:(DE-Ds200)20121206GSI
|k GSI
|b 7
|6 P:(DE-Ds200)OR1282
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF3-890
|0 G:(DE-HGF)POF3-899
|2 G:(DE-HGF)POF3-800
|v ohne Topic
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
913 1 _ |a DE-HGF
|0 G:(DE-HGF)POF1-300
|v Gesundheit
|9 G:(DE-HGF)POF1-310
|x 1
|4 G:(DE-HGF)POF
|1 G:(DE-HGF)POF1-310
|3 G:(DE-HGF)POF1
|2 G:(DE-HGF)POF1-300
|b Gesundheit
|l Krebsforschung
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b RADIAT RES : 2014
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Ds200)BIO-20160831OR354
|k BIO
|l Biophysik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Ds200)20110831OR021
980 _ _ |a I:(DE-Ds200)BIO-20160831OR354
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21